Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
News|Articles|December 11, 2019
Machine Inspects Lyo Seals
The Raised Stopper Inspection machine from Antares Vision verifies proper sealing of freeze-dried vials.
Antares Vision’s Raised Stopper Inspection (RSI) machine verifies proper sealing of freeze-dried vials. The standalone machine is designed for installation in Grade-A cleanrooms and operates with laminar air flow.
The machine’s 1-mm detection threshold identifies stoppers that are not wholly adhered to the vial collar, and it can inspect up to 300 units/min. The module is compatible with a wide array of vials from 10–300 mL in volume with a 20–32-mm cap range. The overall length of the RSI is 76 cm, and it can be installed as a drop-in solution in existing lines.
Source:
Related to this article
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
PharmTech’s Weekly Roundup—September 25, 2026
3
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5